Haughan; Alan Findlay
Patent Applications and Registrations
Patent applications and USPTO patent grants for Haughan; Alan Findlay.The latest application filed is for "quinoline and quinoxaline derivatives as kinase inhibitors".
- Haughan; Alan Findlay - Saffron Walden Essex N/A GB
- Haughan; Alan Findlay - Saffron Walden GB
- Haughan; Alan Findlay - Chesterford Research Park GB
- Haughan; Alan Findlay - Slough GB
- Haughan; Alan Findlay - Essex GB
- Haughan; Alan Findlay - Berkshire GB
- Haughan, Alan Findlay - Cambridge GB
| Patent | Date |
|---|---|
| Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors Grant 8,957,090 - Raphy , et al. February 17, 2 | 2015-02-17 |
| Triazine derivatives as kinase inhibitors Grant 8,785,628 - Allen , et al. July 22, 2 | 2014-07-22 |
| Quinoline derivatives as kinase inhibitors Grant 8,653,105 - Allen , et al. February 18, 2 | 2014-02-18 |
| Quinoline derivatives as kinase inhibitors Grant 8,637,543 - Burli , et al. January 28, 2 | 2014-01-28 |
| Fused pyridine and pyrazine derivatives as kinase inhibitors Grant 8,513,284 - Allen , et al. August 20, 2 | 2013-08-20 |
| Quinoline and Quinoxaline Derivatives as Kinase Inhibitors App 20130018057 - Burli; Roland ; et al. | 2013-01-17 |
| Fused Bicyclic Pyridine and Pyrazine Derivatives as Kinase Inhibitors App 20130012515 - Raphy; Gilles ; et al. | 2013-01-10 |
| Quinoline and Quinoxaline Derivatives as Kinase Inhibitors App 20130012517 - Allen; Daniel Rees ; et al. | 2013-01-10 |
| Fused thiophene derivatives as kinase inhibitors Grant 8,324,204 - Alexander , et al. December 4, 2 | 2012-12-04 |
| Fused thiazole derivatives as kinase inhibitors Grant 8,242,116 - Alexander , et al. August 14, 2 | 2012-08-14 |
| Fused Bicyclic Pyrazole Derivatives As Kinase Inhibitors App 20120095005 - Allen; Daniel Rees ; et al. | 2012-04-19 |
| Fused Pyridine And Pyrazine Derivatives As Kinase Inhibitors App 20120077815 - Allen; Daniel Rees ; et al. | 2012-03-29 |
| Triazine Derivatives as Kinase Inhibitors App 20120053167 - Allen; Daniel Rees ; et al. | 2012-03-01 |
| Fused Thiophene Derivatives as Kinase Inhibitors App 20100305066 - Alexander; Rikki Peter ; et al. | 2010-12-02 |
| Fused Thiazole Derivatives as Kinase Inhibitors App 20100137302 - Alexander; Rikki Peter ; et al. | 2010-06-03 |
| Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatory disorders App 20030171413 - Owen, David Alan ; et al. | 2003-09-11 |
| Quinolone derivatives App 20030105073 - Haughan, Alan Findlay ; et al. | 2003-06-05 |
| Heterocyclic compounds and their therapeutic use Grant 6,403,791 - Dyke , et al. June 11, 2 | 2002-06-11 |
| Benzothiazole compounds and their therapeutic use Grant 6,313,116 - Dyke , et al. November 6, 2 | 2001-11-06 |
| Heterocyclic compounds and their therapeutic use Grant 6,169,090 - Dyke , et al. January 2, 2 | 2001-01-02 |
| Quinolines and their therapeutic use Grant 6,069,151 - Dyke , et al. May 30, 2 | 2000-05-30 |
| Quinolones and their therapeutic use Grant 5,891,878 - Beasley , et al. April 6, 1 | 1999-04-06 |
| Quinolones and their therapeutic use Grant 5,753,666 - Beasley , et al. May 19, 1 | 1998-05-19 |
| Hypoxanthine and guanine compounds Grant 5,736,549 - Beasley , et al. April 7, 1 | 1998-04-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 